Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 226 entries
Sorted by: Best Match Show Resources per page
Effect of tissue inhibitor of metalloproteinases 3 on DLK1 shedding in cultured human pre-adipocytes and implications for adipose tissue remodelling.

Lancet (London, England)

Fenech M, Gavrilovic J, Turner J.
PMID: 26312857
Lancet. 2015 Feb 26;385:S35. doi: 10.1016/S0140-6736(15)60350-6.

BACKGROUND: Metabolically unhealthy obesity is associated with adipose tissue inflammation and increased risk of type 2 diabetes. Dysfunctional adipose tissue remodelling has been implicated in development of metabolically unhealthy obesity, but the pathogenesis remains poorly characterised. We hypothesised that...

Cite
Fenech M, Gavrilovic J, Turner J. Effect of tissue inhibitor of metalloproteinases 3 on DLK1 shedding in cultured human pre-adipocytes and implications for adipose tissue remodelling. Lancet. 2015;385:S35doi: 10.1016/S0140-6736(15)60350-6.
Fenech, M., Gavrilovic, J., & Turner, J. (2015). Effect of tissue inhibitor of metalloproteinases 3 on DLK1 shedding in cultured human pre-adipocytes and implications for adipose tissue remodelling. Lancet (London, England), 385S35. https://doi.org/10.1016/S0140-6736(15)60350-6
Fenech, Matthew, et al. "Effect of tissue inhibitor of metalloproteinases 3 on DLK1 shedding in cultured human pre-adipocytes and implications for adipose tissue remodelling." Lancet (London, England) vol. 385 (2015): S35. doi: https://doi.org/10.1016/S0140-6736(15)60350-6
Fenech M, Gavrilovic J, Turner J. Effect of tissue inhibitor of metalloproteinases 3 on DLK1 shedding in cultured human pre-adipocytes and implications for adipose tissue remodelling. Lancet. 2015 Feb 26;385:S35. doi: 10.1016/S0140-6736(15)60350-6. PMID: 26312857.
Copy Download .nbib Format: NLM
Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice.

Hepatology research : the official journal of the Japan Society of Hepatology

Hori T, Uemoto S, Walden LB, Chen F, Baine AM, Hata T, Kogure T, Nguyen JH.
PMID: 23672352
Hepatol Res. 2014 Jun;44(6):651-62. doi: 10.1111/hepr.12161. Epub 2013 Jun 20.

AIM: If progressive liver injury and subsequent hepatic encephalopathy can be prohibited in fulminant liver failure (FLF), it would be ideal for intensive care of FLF and provide an expanded opportunity for liver transplantation (LT). We hypothesized that matrix...

Cite
Hori T, Uemoto S, Walden LB, et al. Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice. Hepatol Res. 2013;44(6):651-62doi: 10.1111/hepr.12161.
Hori, T., Uemoto, S., Walden, L. B., Chen, F., Baine, A. M., Hata, T., Kogure, T., & Nguyen, J. H. (2014). Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice. Hepatology research : the official journal of the Japan Society of Hepatology, 44(6), 651-62. https://doi.org/10.1111/hepr.12161
Hori, Tomohide, et al. "Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice." Hepatology research : the official journal of the Japan Society of Hepatology vol. 44,6 (2014): 651-62. doi: https://doi.org/10.1111/hepr.12161
Hori T, Uemoto S, Walden LB, Chen F, Baine AM, Hata T, Kogure T, Nguyen JH. Matrix metalloproteinase-9 as a therapeutic target for the progression of fulminant liver failure with hepatic encephalopathy: A pilot study in mice. Hepatol Res. 2014 Jun;44(6):651-62. doi: 10.1111/hepr.12161. Epub 2013 Jun 20. PMID: 23672352.
Copy Download .nbib Format: NLM
Targeting Extracellular Cyclophilins Ameliorates Disease Progression in Experimental Biliary Atresia.

Molecular medicine (Cambridge, Mass.)

Iordanskaia T, Malesevic M, Fischer G, Pushkarsky T, Bukrinsky M, Nadler EP.
PMID: 26225831
Mol Med. 2015 Oct;21(1):657-664. doi: 10.2119/molmed.2015.00076. Epub 2015 Jul 24.

Biliary atresia (BA) is a devastating liver disease of unknown etiology affecting children generally within the first 3 months of life. The disease is manifested by inflammation and subsequent obstruction of the extrahepatic bile ducts, fibrosis and liver failure....

Cite
Iordanskaia T, Malesevic M, Fischer G, et al. Targeting Extracellular Cyclophilins Ameliorates Disease Progression in Experimental Biliary Atresia. Mol Med. 2015;21(1):657-664doi: 10.2119/molmed.2015.00076.
Iordanskaia, T., Malesevic, M., Fischer, G., Pushkarsky, T., Bukrinsky, M., & Nadler, E. P. (2015). Targeting Extracellular Cyclophilins Ameliorates Disease Progression in Experimental Biliary Atresia. Molecular medicine (Cambridge, Mass.), 21(1), 657-664. https://doi.org/10.2119/molmed.2015.00076
Iordanskaia, Tatiana, et al. "Targeting Extracellular Cyclophilins Ameliorates Disease Progression in Experimental Biliary Atresia." Molecular medicine (Cambridge, Mass.) vol. 21,1 (2015): 657-664. doi: https://doi.org/10.2119/molmed.2015.00076
Iordanskaia T, Malesevic M, Fischer G, Pushkarsky T, Bukrinsky M, Nadler EP. Targeting Extracellular Cyclophilins Ameliorates Disease Progression in Experimental Biliary Atresia. Mol Med. 2015 Oct;21(1):657-664. doi: 10.2119/molmed.2015.00076. Epub 2015 Jul 24. PMID: 26225831; PMCID: PMC4749494.
Copy Download .nbib Format: NLM
Tumor suppression by stromal TIMPs.

Molecular & cellular oncology

Shimoda M, Jackson HW, Khokha R.
PMID: 27314104
Mol Cell Oncol. 2016 Mar 30;3(3):e975082. doi: 10.4161/23723556.2014.975082. eCollection 2016 May.

The tumor stroma has the capacity to drive cancer progression, although the mechanisms governing these effects are incompletely understood. Recently, we reported that deletion of tissue inhibitor of metalloproteinases (Timps) in fibroblasts unleashes the function of cancer-associated fibroblasts and...

Cite
Shimoda M, Jackson HW, Khokha R. Tumor suppression by stromal TIMPs. Mol Cell Oncol. 2016;3(3):e975082doi: 10.4161/23723556.2014.975082.
Shimoda, M., Jackson, H. W., & Khokha, R. (2016). Tumor suppression by stromal TIMPs. Molecular & cellular oncology, 3(3), e975082. https://doi.org/10.4161/23723556.2014.975082
Shimoda, Masayuki, et al. "Tumor suppression by stromal TIMPs." Molecular & cellular oncology vol. 3,3 (2016): e975082. doi: https://doi.org/10.4161/23723556.2014.975082
Shimoda M, Jackson HW, Khokha R. Tumor suppression by stromal TIMPs. Mol Cell Oncol. 2016 Mar 30;3(3):e975082. doi: 10.4161/23723556.2014.975082. eCollection 2016 May. PMID: 27314104; PMCID: PMC4909426.
Copy Download .nbib Format: NLM
Effect of Hijikia fusiforme extracts on degenerative osteoarthritis in vitro and in vivo models.

Nutrition research and practice

Kwon HO, Lee M, Kim OK, Ha Y, Jun W, Lee J.
PMID: 27247722
Nutr Res Pract. 2016 Jun;10(3):265-73. doi: 10.4162/nrp.2016.10.3.265. Epub 2016 Apr 01.

BACKGROUND/OBJECTIVES: The inhibitory effect of Hijikia fusiforme (HF) extracts on degenerative osteoarthritis was examined in primary cultured rat cartilage cells and a monosodium iodoacetate (MIA)-induced osteoarthritis rat model.MATERIALS/METHODS: In vitro, cell survival and the expression of matrix metalloproteinases (MMPs),...

Cite
Kwon HO, Lee M, Kim OK, et al. Effect of Hijikia fusiforme extracts on degenerative osteoarthritis in vitro and in vivo models. Nutr Res Pract. 2016;10(3):265-73doi: 10.4162/nrp.2016.10.3.265.
Kwon, H. O., Lee, M., Kim, O. K., Ha, Y., Jun, W., & Lee, J. (2016). Effect of Hijikia fusiforme extracts on degenerative osteoarthritis in vitro and in vivo models. Nutrition research and practice, 10(3), 265-73. https://doi.org/10.4162/nrp.2016.10.3.265
Kwon, Han Ol, et al. "Effect of Hijikia fusiforme extracts on degenerative osteoarthritis in vitro and in vivo models." Nutrition research and practice vol. 10,3 (2016): 265-73. doi: https://doi.org/10.4162/nrp.2016.10.3.265
Kwon HO, Lee M, Kim OK, Ha Y, Jun W, Lee J. Effect of Hijikia fusiforme extracts on degenerative osteoarthritis in vitro and in vivo models. Nutr Res Pract. 2016 Jun;10(3):265-73. doi: 10.4162/nrp.2016.10.3.265. Epub 2016 Apr 01. PMID: 27247722; PMCID: PMC4880725.
Copy Download .nbib Format: NLM
Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer.

Indian journal of clinical biochemistry : IJCB

Singh RD, Haridas N, Patel JB, Shah FD, Shukla SN, Shah PM, Patel PS.
PMID: 21731196
Indian J Clin Biochem. 2010 Jul;25(3):250-9. doi: 10.1007/s12291-010-0060-8. Epub 2010 Aug 25.

Matrix metalloproteinases (MMPs) have been implicated in invasion and metastasis of various malignancies. The study evaluated a comprehensive profile of MMP-2 and MMP-9 and their inhibitors, tissue inhibitor of metalloproteinases-2 (TIMP-2) and tissue inhibitor of metalloproteinases-1 (TIMP-1), respectively in...

Cite
Singh RD, Haridas N, Patel JB, et al. Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer. Indian J Clin Biochem. 2010;25(3):250-9doi: 10.1007/s12291-010-0060-8.
Singh, R. D., Haridas, N., Patel, J. B., Shah, F. D., Shukla, S. N., Shah, P. M., & Patel, P. S. (2010). Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer. Indian journal of clinical biochemistry : IJCB, 25(3), 250-9. https://doi.org/10.1007/s12291-010-0060-8
Singh, Ragini D, et al. "Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer." Indian journal of clinical biochemistry : IJCB vol. 25,3 (2010): 250-9. doi: https://doi.org/10.1007/s12291-010-0060-8
Singh RD, Haridas N, Patel JB, Shah FD, Shukla SN, Shah PM, Patel PS. Matrix metalloproteinases and their inhibitors: correlation with invasion and metastasis in oral cancer. Indian J Clin Biochem. 2010 Jul;25(3):250-9. doi: 10.1007/s12291-010-0060-8. Epub 2010 Aug 25. PMID: 21731196; PMCID: PMC3001841.
Copy Download .nbib Format: NLM
Retraction notice. "Genetic aberrations in tissue inhibitor of metalloproteinases-3 lead to manifestations of the myofibroblast phenotye in mouse fibroblasts and fibroblasts of patients with Sorsby fundus dystrophy" by G. M. Soboleva and G. T. Sukhikh, Vol. 143, No. 2, pp. 231-235, February 2007.

Bulletin of experimental biology and medicine

[No authors listed]
PMID: 20082502
Bull Exp Biol Med. 2009 May;147(5):669. doi: 10.1007/s10517-009-0584-1.

No abstract available.

Cite
Retraction notice. "Genetic aberrations in tissue inhibitor of metalloproteinases-3 lead to manifestations of the myofibroblast phenotye in mouse fibroblasts and fibroblasts of patients with Sorsby fundus dystrophy" by G. M. Soboleva and G. T. Sukhikh, Vol. 143, No. 2, pp. 231-235, February 2007. Bull Exp Biol Med. 2009;147(5):669doi: 10.1007/s10517-009-0584-1.
(2009). Retraction notice. "Genetic aberrations in tissue inhibitor of metalloproteinases-3 lead to manifestations of the myofibroblast phenotye in mouse fibroblasts and fibroblasts of patients with Sorsby fundus dystrophy" by G. M. Soboleva and G. T. Sukhikh, Vol. 143, No. 2, pp. 231-235, February 2007. Bulletin of experimental biology and medicine, 147(5), 669. https://doi.org/10.1007/s10517-009-0584-1
"Retraction notice. "Genetic aberrations in tissue inhibitor of metalloproteinases-3 lead to manifestations of the myofibroblast phenotye in mouse fibroblasts and fibroblasts of patients with Sorsby fundus dystrophy" by G. M. Soboleva and G. T. Sukhikh, Vol. 143, No. 2, pp. 231-235, February 2007." Bulletin of experimental biology and medicine vol. 147,5 (2009): 669. doi: https://doi.org/10.1007/s10517-009-0584-1
Retraction notice. "Genetic aberrations in tissue inhibitor of metalloproteinases-3 lead to manifestations of the myofibroblast phenotye in mouse fibroblasts and fibroblasts of patients with Sorsby fundus dystrophy" by G. M. Soboleva and G. T. Sukhikh, Vol. 143, No. 2, pp. 231-235, February 2007. Bull Exp Biol Med. 2009 May;147(5):669. doi: 10.1007/s10517-009-0584-1. PMID: 20082502.
Copy Download .nbib Format: NLM
Dieckol from Ecklonia cava Regulates Invasion of Human Fibrosarcoma Cells and Modulates MMP-2 and MMP-9 Expression via NF-κB Pathway.

Evidence-based complementary and alternative medicine : eCAM

Zhang C, Li Y, Qian ZJ, Lee SH, Li YX, Kim SK.
PMID: 21826183
Evid Based Complement Alternat Med. 2011;2011:140462. doi: 10.1155/2011/140462. Epub 2011 Aug 04.

The matrix metalloproteinase (MMP) family is involved in the breakdown of extracellular matrix in normal physiological processes, as well as in the disease processes such as arthritis and cancer metastasis. In the present study, dieckol was obtained with high...

Cite
Zhang C, Li Y, Qian ZJ, et al. Dieckol from Ecklonia cava Regulates Invasion of Human Fibrosarcoma Cells and Modulates MMP-2 and MMP-9 Expression via NF-κB Pathway. Evid Based Complement Alternat Med. 2011;2011:140462doi: 10.1155/2011/140462.
Zhang, C., Li, Y., Qian, Z. J., Lee, S. H., Li, Y. X., & Kim, S. K. (2011). Dieckol from Ecklonia cava Regulates Invasion of Human Fibrosarcoma Cells and Modulates MMP-2 and MMP-9 Expression via NF-κB Pathway. Evidence-based complementary and alternative medicine : eCAM, 2011140462. https://doi.org/10.1155/2011/140462
Zhang, Chen, et al. "Dieckol from Ecklonia cava Regulates Invasion of Human Fibrosarcoma Cells and Modulates MMP-2 and MMP-9 Expression via NF-κB Pathway." Evidence-based complementary and alternative medicine : eCAM vol. 2011 (2011): 140462. doi: https://doi.org/10.1155/2011/140462
Zhang C, Li Y, Qian ZJ, Lee SH, Li YX, Kim SK. Dieckol from Ecklonia cava Regulates Invasion of Human Fibrosarcoma Cells and Modulates MMP-2 and MMP-9 Expression via NF-κB Pathway. Evid Based Complement Alternat Med. 2011;2011:140462. doi: 10.1155/2011/140462. Epub 2011 Aug 04. PMID: 21826183; PMCID: PMC3151525.
Copy Download .nbib Format: NLM
The expressions of inflammatory factors and tissue inhibitor of matrix metalloproteinase-2 in human chronic periodontitis with type 2 diabetes mellitus.

Journal of periodontal & implant science

Shin DS, Park JW, Suh JY, Lee JM.
PMID: 20498757
J Periodontal Implant Sci. 2010 Feb;40(1):33-8. doi: 10.5051/jpis.2010.40.1.33. Epub 2010 Feb 28.

PURPOSE: The purpose of this study was to observe and quantify the expression of interleukin-4 (IL-4), interferon-gamma (IFN-gamma), and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in the gingival tissue of patients with type 2 diabetes mellitus (DM) and healthy...

Cite
Shin DS, Park JW, Suh JY, et al. The expressions of inflammatory factors and tissue inhibitor of matrix metalloproteinase-2 in human chronic periodontitis with type 2 diabetes mellitus. J Periodontal Implant Sci. 2010;40(1):33-8doi: 10.5051/jpis.2010.40.1.33.
Shin, D. S., Park, J. W., Suh, J. Y., & Lee, J. M. (2010). The expressions of inflammatory factors and tissue inhibitor of matrix metalloproteinase-2 in human chronic periodontitis with type 2 diabetes mellitus. Journal of periodontal & implant science, 40(1), 33-8. https://doi.org/10.5051/jpis.2010.40.1.33
Shin, Dong-Seok, et al. "The expressions of inflammatory factors and tissue inhibitor of matrix metalloproteinase-2 in human chronic periodontitis with type 2 diabetes mellitus." Journal of periodontal & implant science vol. 40,1 (2010): 33-8. doi: https://doi.org/10.5051/jpis.2010.40.1.33
Shin DS, Park JW, Suh JY, Lee JM. The expressions of inflammatory factors and tissue inhibitor of matrix metalloproteinase-2 in human chronic periodontitis with type 2 diabetes mellitus. J Periodontal Implant Sci. 2010 Feb;40(1):33-8. doi: 10.5051/jpis.2010.40.1.33. Epub 2010 Feb 28. PMID: 20498757; PMCID: PMC2872806.
Copy Download .nbib Format: NLM
Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity.

Therapeutic advances in chronic disease

Meszaros E, Malemud CJ.
PMID: 23342237
Ther Adv Chronic Dis. 2012 Sep;3(5):219-29. doi: 10.1177/2040622312454157.

Primary osteoarthritis (OA) is a musculoskeletal disorder of unknown etiology. OA is characterized by an imbalance between anabolism and catabolism in, and altered homeostasis of articular cartilage. Matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinase with thrombospondin motif are...

Cite
Meszaros E, Malemud CJ. Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity. Ther Adv Chronic Dis. 2012;3(5):219-29doi: 10.1177/2040622312454157.
Meszaros, E., & Malemud, C. J. (2012). Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity. Therapeutic advances in chronic disease, 3(5), 219-29. https://doi.org/10.1177/2040622312454157
Meszaros, Evan, and Malemud, Charles J. "Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity." Therapeutic advances in chronic disease vol. 3,5 (2012): 219-29. doi: https://doi.org/10.1177/2040622312454157
Meszaros E, Malemud CJ. Prospects for treating osteoarthritis: enzyme-protein interactions regulating matrix metalloproteinase activity. Ther Adv Chronic Dis. 2012 Sep;3(5):219-29. doi: 10.1177/2040622312454157. PMID: 23342237; PMCID: PMC3539270.
Copy Download .nbib Format: NLM
Enhanced expression of tissue inhibitor of metalloproteinases-4 gene in human osteoarthritic synovial membranes and its differential regulation by cytokines in chondrocytes.

The open rheumatology journal

Huang W, Mabrouk ME, Sylvester J, Dehnade F, Zafarullah M.
PMID: 22216069
Open Rheumatol J. 2011;5:81-7. doi: 10.2174/1874312901105010081. Epub 2011 Nov 29.

OBJECTIVE: Tissue inhibitors of metalloproteinases (TIMPs) are multi-functional proteins with matrix metalloproteinases-inhibiting activities. We studied expression of anti-inflammatory, TIMP-4 gene in human joint tissues and its regulation by arthritis-associated cytokines.RESULTS: TIMP-4 RNA expression originating from synovial fibroblasts was significantly...

Cite
Huang W, Mabrouk ME, Sylvester J, et al. Enhanced expression of tissue inhibitor of metalloproteinases-4 gene in human osteoarthritic synovial membranes and its differential regulation by cytokines in chondrocytes. Open Rheumatol J. 2011;5:81-7doi: 10.2174/1874312901105010081.
Huang, W., Mabrouk, M. E., Sylvester, J., Dehnade, F., & Zafarullah, M. (2011). Enhanced expression of tissue inhibitor of metalloproteinases-4 gene in human osteoarthritic synovial membranes and its differential regulation by cytokines in chondrocytes. The open rheumatology journal, 581-7. https://doi.org/10.2174/1874312901105010081
Huang, Wensheng, et al. "Enhanced expression of tissue inhibitor of metalloproteinases-4 gene in human osteoarthritic synovial membranes and its differential regulation by cytokines in chondrocytes." The open rheumatology journal vol. 5 (2011): 81-7. doi: https://doi.org/10.2174/1874312901105010081
Huang W, Mabrouk ME, Sylvester J, Dehnade F, Zafarullah M. Enhanced expression of tissue inhibitor of metalloproteinases-4 gene in human osteoarthritic synovial membranes and its differential regulation by cytokines in chondrocytes. Open Rheumatol J. 2011;5:81-7. doi: 10.2174/1874312901105010081. Epub 2011 Nov 29. PMID: 22216069; PMCID: PMC3245407.
Copy Download .nbib Format: NLM
Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy.

Journal of cell communication and signaling

Van Geest RJ, Klaassen I, Lesnik-Oberstein SY, Tan HS, Mura M, Goldschmeding R, Van Noorden CJ, Schlingemann RO.
PMID: 23054594
J Cell Commun Signal. 2013 Mar;7(1):1-9. doi: 10.1007/s12079-012-0178-y. Epub 2012 Oct 02.

In proliferative diabetic retinopathy (PDR), vascular endothelial growth factor (VEGF) and CCN2 (connective tissue growth factor; CTGF) cause blindness by neovascularization and subsequent fibrosis. This angio-fibrotic switch is associated with a shift in the balance between vitreous levels of...

Cite
Van Geest RJ, Klaassen I, Lesnik-Oberstein SY, et al. Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy. J Cell Commun Signal. 2012;7(1):1-9doi: 10.1007/s12079-012-0178-y.
Van Geest, R. J., Klaassen, I., Lesnik-Oberstein, S. Y., Tan, H. S., Mura, M., Goldschmeding, R., Van Noorden, C. J., & Schlingemann, R. O. (2013). Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy. Journal of cell communication and signaling, 7(1), 1-9. https://doi.org/10.1007/s12079-012-0178-y
Van Geest, Rob J, et al. "Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy." Journal of cell communication and signaling vol. 7,1 (2013): 1-9. doi: https://doi.org/10.1007/s12079-012-0178-y
Van Geest RJ, Klaassen I, Lesnik-Oberstein SY, Tan HS, Mura M, Goldschmeding R, Van Noorden CJ, Schlingemann RO. Vitreous TIMP-1 levels associate with neovascularization and TGF-β2 levels but not with fibrosis in the clinical course of proliferative diabetic retinopathy. J Cell Commun Signal. 2013 Mar;7(1):1-9. doi: 10.1007/s12079-012-0178-y. Epub 2012 Oct 02. PMID: 23054594; PMCID: PMC3590360.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 226 entries